Publication Archives: 2012
-
(2011)
Tousi, A.S., Buck, D.J., Curtis, T., Davis, R.L.
α-Synuclein potentiates interleukin-1β-induced CXCL10 expression in human A172 astrocytoma cells.
Neuroscience Letters; Volume 507, Issue 2, 24 January 2012, Pages 133–136 DOI /10.1016/j.neulet.2011.12.001.
-
(2011)
Martin, Z. S., Neugebauer, V., Dineley, K. T., Kayed, R., Zhang, W., Reese, L. C. and Taglialatela, G.,
α-Synuclein oligomers oppose long-term potentiation and impair memory through a calcineurin-dependent mechanism: relevance to human synucleopathic diseases..
Journal of Neurochemistry; 120: 440–452. 2012 Feb; doi: 10.1111/j.1471-4159.2011.07576.x.
-
(2011)
Kovacs, GG, Wagner, U., Dumont, B., Pikkarainen, M., Osman, AA, Streichenberger, N., Leisser, I., Verchère, J., Baron, T. and Alafuzoff, I., et al.
An antibody with high reactivity for disease-associated α-synuclein reveals extensive brain pathology.
Acta Neuropathologica; 2012, DOI: 10.1007/s00401-012-0964-x.
-
(2011)
Vasudevaraju, P., Guerrero, E., Hegde, ML, Collen, TB, Britton, GB, and Rao, KS
New evidence on α-synuclein and Tau binding to conformation and sequence specific GC* rich DNA: Relevance to neurological disorders.
J Pharm Bioallied Sci.; 2012 Apr-Jun; 4(2): 112–117. doi: 10.4103/0975-7406.9481; PMCID: PMC3341714.
-
(2011)
Prabhudesai, S., Sinha, S., Attar, A., Kotagiri, A., Fitzmaurice, AG, Lakshmanan, R., Ivanova, MI, Loo, JA, Klärner, FG and Schrader, T., et al.
A Novel “Molecular Tweezer” Inhibitor of α-Synuclein Neurotoxicity in Vitro and in Vivo.
Neurotherapeutics; Volume 9, Number 2, 464-476, DOI: 10.1007/s13311-012-0105-1.
-
(2011)
Tavassoly, O., Lee, J.S.
Methamphetamine binds to α-synuclein and causes a conformational change which can be detected by nanopore analysis.
FEBS Letters; In Press, Uncorrected proof (5 July 2012), doi:10.1016/j.febslet.2012.06.040.
-
(2011)
Maetzler W, Langkamp M, Lerche S, Godau J, Brockmann K, Gaenslen A, Huber H, Wurster I, Niebler R, Eschweiler GW, Berg D.
Lowered Serum Amyloid-β1-42 Autoantibodies in Individuals with Lifetime Depression.
Journal of Alzheimer’s Disease; 2012 Jul 5. [Epub ahead of print] DOI: 10.3233/JAD-2012-120625.
-
(2011)
Michael Bidinosti, Derya R. Shimshek, Brit Mollenhauer, David Marcellin, Tatjana Schweizer, Gregor P. Lotz, Michael G. Schlossmacher, Andreas Weiss
https://www.ncbi.nlm.nih.gov/pubmed/22843695. Novel one-step immunoassays to quantify α-synuclein: applications for biomarker development and high-throughput screening.
J Biol Chem.; DOI: 10.1074/jbc.M112.379792.
-
(2011)
Smith LM, Klaver AC, Coffey MP, Dang L, Loeffler DA.
Effects of intravenous immunoglobulin on alpha synuclein aggregation and neurotoxicity.
Int Immunopharmacol; 2012 Sep 28. pii: S1567-5769(12)00270-6. doi: 10.1016/j.intimp.2012.09.007..
